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Genetic Modulation of the Cellular
Antioxidant Defense Capacity
by Paul Amstad* and Peter Cerutti*
Oxidants are ubiquitous in our aerobic environment. While they are always toxic, they can also exert
pathophysiological effects at low concentrations and play an etiological role in human disease. For ex-
ample, oxidants can stimulate cell growth and act as tumor promoters. The cellular antioxidant defense
system attenuates the effect of oxidants and consists of low molecular weight components and several
enzymes. Most important are catalase (CAT), superoxide dismutases (SOD), and glutathione peroxidase.
We are attempting to elucidate the role of CAT and Cu,Zn-SOD in oxidant tumor promotion of mouse
epidermal cells JB6. We have found that the promotable clone 41 possesses 2- to 3-fold higher levels of
activity, protein, and stationary mRNA of CAT and Cu,Zn-SOD than does the nonpromotable clone 30.
We propose that the growth-stimulatory effect of oxidants is more pronounced in promotable clone 41
because it is betterprotected from oxidant toxicity. Inorder to corroborate this model, we have constructed
JB6 cells with higher levels of Cu,Zn-SOD and CAT by transfection with expression vectors containing
cDNA forthese genes. On the other hand, cells with decreased amounts ofCu,Zn-SOD have been obtained
by their stable transfection with a vector containing SOD-cDNA in the antisense orientation. These cell
clones with modified antioxidant enzyme complements are being characterized. In particular, their pro-
motability by oxidants and their sensitivity to killing and oxidative macromolecular damage are being
measured. Certain tumor promoters that lack oxidizing properties may generate a cellular prooxidant
state by a variety ofmechanisms. For example, it had been reported that the phorbol ester TPA decreases
the activities ofCAT and SOD in mouse skin. We found for JB6 cells that this loss ofenzyme activity was
due to a decrease in the steady-state concentrations of CAT- and SOD-mRNA. The observed decreases in
CAT and SOD can be considered as part of the complex reprogramming of gene expression that is set in
motion by TPA.
Introduction
Oxidants are toxic to most cells. They inflict damage
on several targets, most importantly to lipids, proteins,
and DNA. Cells are protected by multiple levels of an-
tioxidant defenses. The notion that a gradual decrease
in these defenses might play a role in the aging process
has been considered for many years but remains con-
troversial. Comparative studies of the antioxidant ca-
pacity of tissues of different animal species have sug-
gested a positive correlation with the maximal lifespan
potential (1). Interestingly, the increase in lifespan of
rats by dietary restriction was accompanied by an in-
crease in the activities, mRNA contents, and rates of
transcription ofthe antioxidant enzymes catalase (CAT)
and Cu, Zn-superoxide dismutase (SOD) (A. Richard-
son, personal communication). Besides playing a role in
aging, oxidants possess carcinogenic potential. There is
convincing evidence that low doses of exogenous oxi-
dants can exert a growth-promoting effect and act as
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natural promotersintumorigenesis (2v-4). Thefollowing
principalalternatives canbe distinguished forthe action
ofoxidant promoters. Oxidants and cellular prooxidant
states represent signals for the selective induction of
differentiation or growth in a particular subpopulation
ofepidermalcells. Indeed, aburstofextracellularactive
oxygen (AO) induced the competence-related protoon-
cogenes c-fos and c-myc in mouse epidermal cells JB6
(5,6). Specific subpopulations may differ in their sus-
ceptibilities to the cytostatic and cytotoxic effects of
oxidants (7,8). In support ofthe second alternative, we
found that the cytostatic effect of AO, DNA strand
breakage, and poly-ADP-ribosylation were more pro-
nounced in the nonpromotable clone 30 than in the pro-
motable clone 41 (9).
Because of the role of oxidants in degenerative dis-
ease, aging, and carcinogenesis, much research is being
concentrated on the elucidation ofthe mode ofaction of
oxidants and on the characterization ofthe cellular an-
tioxidant defense systems. All cells contain low molec-
ular weight antioxidants such as glutathione, cysteine,
ascorbate, a.-tocopherol, urate, and carotinoids. In ad-
dition, they contain several antioxidant enzymes, most
importantly glutathione peroxidase (GPx), glutathione-
S-transferase, several SODs, and CAT. The individualAMSTAD AND CERUTTI
contributions ofthese multiple, interacting components
in intact cells is only poorly understood. In particular,
the relative contributions of the antioxidant enzymes
under in vivo conditions remain unknown despite the
fact that their enzymology has been investigated in de-
tail (10).
Workwith expression vectors containingCu,Zn-SOD
indicates that an oversupply ofthis enzyme is not nec-
essarily beneficial to a mammalian cell and can even
cause increased lipid peroxidation (11). It has been sug-
gested that the presence ofthree genes for Cu,Zn-SOD
inthe aging-related disease Down's Syndrome mayplay
a role in its etiology (10,12). Interestingly, overexpres-
sion of Cu,Zn-SOD in human cells can result in a com-
pensatory increase in GPx activity (13). While work
with expression vectors can yield useful information, it
has the drawbackthat cells are flooded with aparticular
protein and that there is no guarantee for proper in-
tracellular compartmentalization.
In our work we have investigated four aspects ofthe
cellular antioxidant defense in mouse epidermal cells
JB6: a) We have compared the constitutive levels ofthe
major antioxidant enzymes in promotable clone 41 and
nonpromotable clone 30. b) Since the promotional action
of the phorbol-ester promoter 12-0-tetradecanoyl-
phorbol-13-acetate (TPA) on JB6 clone 41 cells is sup-
pressed by the addition of Cu,Zn-SOD (4), we have
studied the effect of TPA on the expression of the an-
tioxidant enzymes. c) We have increased the level of
Cu,Zn-SOD and CAT by the transfection of JB6 cells
with expression vectors containing cDNA for these en-
zymes. d) Alternatively, we are attempting to selec-
tively reduce the level of Cu,Zn-SOD by the antisense
RNA/hybrid arrest approach in JB6 clone 41 cells. We
feel that the use of genetic manipulation to construct
cells that specifically lack a single function represents
a physiological avenue to an understanding of the role
ofthe individual antioxidant enzymes in situ. Although
wehave obtained insights intotheroleofCATinhuman
fibroblasts in studies of cells from patients with the
autosomal recessive disease acatalasia (14), the poor
growthproperties ofthese strainsprohibited theircom-
plete biochemical characterization. We hope that the
availabilityofstabletransfectants ofJB6cellsthatdiffer
only in their content ofa particular antioxidant enzyme
will allow insights into their role in cellular aging and
carcinogenesis under physiological conditions.
Promotable Mouse Epidermal Cells
JB6 Clone 41 Have an Elevated
Antioxidant Defense Capacity
When we measured the specific activities of SOD,
CAT, and GPx in monolayer cultures ofJB6 cells, we
discovered that the promotable clone 41 contained ap-
proximatelytwice the activity ofSOD and CATrelative
to the nonpromotable clone 30, whereas the activities
ofGPx were comparable (15). We took advantage ofthe
cross-activity of a rabbit antibody against human CAT
to assess CAT protein concentrations by Western-blot
analysis. Constitutive amounts ofCAT were 2- to 3-fold
higher in clone 41 than in clone 30, in agreement with
the enzyme activity (15).




probes. Figure 1 shows that the mRNA concentrations
for CAT and SOD were considerably higher in clone 41
than in clone 30, whereas the GPx mRNA levels were
comparable. We conclude that the antioxidant defense
of JB6 clone 41 is superior to that of clone 30. The
difference between the two clones is particularly re-
markable because the two antioxidant enzymes SOD
and CAT are increased coordinately in clone 41. Since
the product of the action of SOD is H202, an increase
in its activity is only beneficial to the cell if it is coun-
terbalanced by a sufficient capacity for the destruction
of H202 (11). This is apparently accomplished in clone
41 by an increase in CAT.
It should be mentioned that SOD and CAT may mu-
tually protect each other from inactivation by active
oxygen (18). A relatively high SOD activity in clone 41
has also been measured by Colburn et al. (19). In con-
trast, the third major antioxidant enzyme GPx was
present at comparable levels in the two clones. The
observed difference appears to be atthe levelofexpres-
sion, as both clones contained the same complement of
SOD and CAT genes according to Southern-blot analy-
sis. Clone 41 also possessed a slightly higher level of
glutathione than did clone 30 (15). The intracellular ca-
pacity for antioxidant defense cannot be assessed with
present technologies. Therefore, it is not possible to
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FIGURE 1. Catalase, glutathione peroxidase, and Cu,Zn-superoxide
dismutase mRNA levels in nonpromotable JB6 clone 30 and in
promotable clone 41. Total RNA was prepared, and 5 or 10 xg
were electrophoresed in 1.4% agarose/formaldehyde denaturing
gels and then transferred to gene screen. The filters were hy-
bridized with 32P-labeled transcripts from SP6 recombinants that
contained cDNAfragments ofhuman CAT, bovine GPx, orhuman
Cu,Zn-SOD, respectively.
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judge whether the coordinate 2- to 3-fold higher level
ofSOD and CAT represents a large or small difference
in total antioxidant defense (15).
The difference in constitutive antioxidant defense of
clone 30 and clone 41 may play a role in their promot-
ability by oxidant promoters. Gindhart and Colburn and
their collaborators had found that only clone 41 was
promotable to anchorage-independent growth by ben-
zoyl peroxide (20), 104 (21), and AO produced by xan-
thine/xanthine oxidase (22). The latter observation was
confirmed in our own laboratory (9). In accordance with
its higher capacity forantioxidant defense, clone 41 was
better protected from AO-induced DNA strand break-
age, poly-ADP-ribosylation and cytotoxicity than was
clone 30 (9). AO strongly induced the growth-compe-
tence-related protooncogenes c-fosandc-mycfromvery
low basal levels in the less protectedJB6 clone 30. Only
weak induction of these protooncogenes was observed
in clone 41, but it occurred on the background of high,
persistent c-myc expression in untreated controls (5,6).
We speculate that the superior constitutive antioxidant
defense of clone 41 protects it from excessive AO tox-
icity and allows growth-related genes to exert their
functions. In contrast, in the nonpromotable clone 30,
cytotoxicity predominates, and the strong transient in-
duction of c-fos and c-myc by AO does not suffice for
growth stimulation.
Downregulation of SOD and CAT by
Phorbol Ester in Mouse Epidermal
Cells JB6
The question whether other promoters that lack ox-
idizing properties may owe at least part oftheir effects
to the induction of a cellular prooxidant state has not
been resolved. There are several indications that TPA
can induce a prooxidant state in epidermal cells. TPA
induces chemiluminescence (23) and decreases the ratio
ofreduced to oxidized glutathione (24). Several antiox-
idants including exogenously added SOD antagonize
TPA promotion (2,4,20,25). In order to exert its anti-
promotional effect, SOD had to be added during the
first 2 hr ofTPA treatment ofJB6 clone 41 or clone 22,
and it was speculated that a protein kinase-C-mediated
process induced a cellular prooxidant state (22). The
report by Solanki et al. (26) that TPAcaused adecrease
in the activities of SOD and CAT in mouse skin sug-
gested that it might induce a prooxidant state by weak-
ening the antioxidant defense. The possibility had been
considered that this decrease reflects the elimination of
a subpopulation of cells with high SOD activity (27).
Evidence had also been presented suggesting that the
apparent decrease in the specific activity of CAT in
mouse epidermis 15 hr after TPA treatment could be
due to an increase in total extractable protein (28).
In our own experiments with mouse epidermal cells
JB6, we found that TPA induced a coordinate loss in
SOD and CAT activities that was at least in part a
consequence of a slow decrease in stationary mRNA
concentrations. It occurred to a comparable degree in
promotable and nonpromotable cells. The observed de-
creases preceded and were more pronounced than the
consequent changesintheenzymeactivities. Withinthe
time frame of our experiments, TPA had no effect on
GPxactivity norGPxmRNAlevels (15). Similarresults
for TPA-induced changes in the activities of CAT and
SOD inJB6 clone 41 were reported by Nakamura et al.
(22). While the extent ofthe TPA-induced decreases in
CATandSODactivities werecomparabletothepresent
work, the drop in activities occurred earlier, i.e., after
2 hr rather than 4 to 8 hr. For CAT, the slower time
course has been corroborated by Western blot analysis
in our work. However, it is noteworthy that a drop in
steady-state CAT and SOD mRNA concentrations was
already discernible 2 hr after TPA treatment in clone
41 and clone 30. Although the decrease in mRNA con-
centrations indicates that the loss in SOD and CAT
activities is at least in part due to genetic downregu-
lation, it does not exclude enzyme inactivation as a con-
tributing factor. Nuclear run-off experiments indicate
thatTPA did not affectthe rate oftranscription ofCAT
and SOD inJB6 cells, and the observed downregulation
of these genes may involve a decrease in messenger
stability (15).
Our results support the notion that TPA can induce
a cellular prooxidant state in mouse epidermal cells. In
contrast to oxidants, low concentrations of TPA are
nontoxic to JB6 cells. Therefore, it is unlikely that dif-
ferential resistance to oxidative stress plays a crucial
role for the promotability ofJB6 cells by TPA. Despite
considerable indirect evidence for a role ofAO, the im-
portance ofthe cellular antioxidant defense in the pro-
motion of epidermal cells by TPA remains unclear.
Transfection of Mouse Epidermal
Cells with Cu,Zn-SOD and CAT
Expression Vectors
The model derived from results described so far pro-
poses that a fine balance between the level of the an-
tioxidant defense, cellulartoxicity, and the induction of
growth-related genes determines promotability by ox-
idants (7,8,10). While a weak antioxidant defense re-
sulting in high toxicity is incompatible with growth, a
very potent defense may scavenge the signal that is
required for genomic induction. We are testing this
model by preparing mouse epidermal cellsJB6 clone 41
with moderately increased levels of Cu,Zn-SOD or
CAT. For this purpose we have transfected cells with
antibiotic-selectable expression vectors containing hu-
man cDNA for Cu,Zn-SOD or a hybrid containing 5'-
cDNA sequences of rat CAT spliced to human CAT
cDNA. [cDNA and/or genes for the major human an-
tioxidant enzymes have been recently cloned in several
laboratories: Cu,Zn-SOD (17), Mn-SOD (29), EC-SOD
(30), CAT (16), GPx (31).] The expression vector for
Cu,Zn-SOD ispD5-derived, containingadenovirus type
5 and 2 promoters as well as the SV40-neomycin re-
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FIGURE 2. pD5-neo-dhfr-based construct containing antioxidant (Cu,Zn-SOD) gene sequences inserted in the antisense direction. Transfected
cells are selected with geneticin, and amplification of the antioxidant gene sequences is attempted by growth in increasing concentrations
ofmethotrexate.
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FIGURE 3. Northern blot of geneticin- and methotrexate-selected JB6 clones that had been transfected with pD5-neo-dhfr-antisense SOD
plasmid. The upper half of the figure shows a blot with a sense-SOD probe reflecting expression of antisense SOD RNA. Although all
transfected clones showexpression, there are large variations in intensity. The filterwas then stripped and hybridized with a corresponding
anti-sense probe for the determination of sense SOD from the endogenous gene (lower half of figure).MODULATION OF CELLULAR ANTIOXIDANT DEFENSE 81
sistance gene cassette; the vector for CAT contains the
HCMV early promoter and an SV40-hygromycin re-
sistance gene cassette.
Of the many antibiotic resistant clones which have
been analyzed so far, only two in each series (i.e., two
SOD and two CAT clones) possess moderate 2- to 3-fold
increased enzyme activities over prolonged periods in
culture (note: the selected clones are cultured routinely
in the presence of low concentrations of antibiotic in
order to prevent the loss of the transfected gene).
Northern-blotting of total RNA from these clones re-
vealed increased expression ofCu,Zn-SOD or CAT, re-
spectively, and Southern blots indicated the presence
ofthe transfected DNA. Western blots with antibodies
against the human proteins showed the presence of
bands corresponding to the human enzymes in addition
to the cross-reacting endogenous mouse protein. The
biological and biochemical characterization ofthese cell
clones is under way. So far, survival experiments fol-
lowing treatment with active oxygen generated by ex-
tracellular xanthine/xanthine oxidase (X/XO) have not
revealed dramatic differences in sensitivity relative to
the nontransfected parent.
Transfection of Mouse Epidermal
Cells with Vectors Containing
Cu,Zn-SOD-cDNA in the Antisense
Orientation
We have constructed a pD5-based expression vector
containing the complete cDNA of human Cu,Zn-SOD
inserted in the antisense orientation downstream ofthe
mouse dihydrofolate reductase gene. Figure 2 shows
the principal features of the plasmid. This expression
vector allows the selection of successfully transfected
cells with geneticin and co-amplification of Cu,Zn-SOD
cDNA sequences by cell growth in increasing concen-
trations of methotrexate. At present we can only give
a progress report. As documented in Figure 3, several
antibiotic-resistant cell clones that show good expres-
sion ofantisense Cu,Zn-SOD RNA have been selected.
In several instances (but not always), higher amounts
of message are detectable following methotrexate se-
lection. The lower half of Figure 3 shows the same
stripped blot reprobed with a corresponding antisense
SODprobe, indicatingthatallclonesexpress sense SOD
RNA from the endogenous gene. All antibiotic-selected
clones were also characterized by Southern-blotting of
Bgl II-restricted DNA with a 600 bp Hind III/EcoRI
fragment ofhuman Cu,Zn-SOD cDNA. Acharacteristic
2.7 kb fragment was detectable in all clones, but there
was no clear evidence for amplification ofthe antisense
SOD sequence upon methotrexate selection. Prelimi-
narymeasurements ofSOD activityrevealed values be-
low controls in some but not all antisense RNA ex-
pressing clones. Activities returned to normal after
long-term culturing (in low concentrations ofgeneticin)
in several clones.
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